Unity Health - St Michael's Hospital
Welcome,         Profile    Billing    Logout  
 6 Trials 
9 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Silverman, Michael
SNAP, NCT05137119: Staphylococcus Aureus Network Adaptive Platform Trial

Recruiting
4
8000
Europe, Canada, RoW
Cefazolin, Penicillin, Benzylpenicillin, Penicillin G, Clindamycin, Lincomycin, Vancomycin, Daptomycin, Effectiveness of early switch to oral antibiotics, Whole body FDG PET/CT Imaging
University of Melbourne, Berry Consultants, McGill University Health Centre/Research Institute of the McGill University Health Centre, Menzies School of Health Research, Aotearoa Clinical Trials, Queensland University of Technology, Sunnybrook Health Sciences Centre, Tan Tock Seng Hospital, Telethon Kids Institute, The Peter Doherty Institute for Infection and Immunity, The University of Queensland, UMC Utrecht, Radboud University Medical Center, King's College London, Rambam Health Care Campus, University College, London, Houston Medical Research Institute
Staphylococcus Aureus Bacteremia
12/28
12/28
CATCO, NCT04330690: Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial

Active, not recruiting
3
2900
Canada
Artesunate, Imatinib, Infliximab, Dexamethasone, LSALT Peptide
Sunnybrook Health Sciences Centre, AbbVie, Apotex Inc., World Health Organization, University of British Columbia, Arch Biopartners Inc.
COVID-19
03/24
05/24
LIVERATION, NCT05201404 / 2021-005286-41: Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis

Recruiting
3
471
Europe, US, RoW
Namodenoson, CF102, Placebo, Inactive control
Can-Fite BioPharma, CanFite BioPharma Ltd.
Hepatocellular Carcinoma, Cirrhosis
02/25
10/25
NCT04247542: ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection

Completed
2
53
US
Ibezapolstat, ACX-362E, Vancomycin, Vancomycin oral
Acurx Pharmaceuticals Inc.
Clostridium Difficile Infection
10/23
11/23
NCT04781387: Evaluation of CRS3123 vs. Oral Vancomycin in Adult Patients With Clostridioides Difficile Infection

Active, not recruiting
2
108
Canada, US
CRS3123, Active Comparator
Crestone, Inc, National Institute of Allergy and Infectious Diseases (NIAID)
Clostridioides Difficile Infection
02/24
04/24
CF102-222PC, NCT06387342: Namodenoson Treatment of Advanced Pancreatic Cancer

Recruiting
2
20
RoW
Namodenoson 25mg, CF102
Can-Fite BioPharma
Pancreatic Adenocarcinoma, Pancreatic Cancer
07/26
12/26
NCT04697810 / 2021-005245-32: Namodenoson in the Treatment of Non-Alcoholic Steatohepatitis (NASH)

Recruiting
2
114
Europe, RoW
Namodenoson, CF102, Placebo, Inactive control
Can-Fite BioPharma, CanFite BioPharma Ltd.
NASH - Nonalcoholic Steatohepatitis
04/25
10/25
NCT04544306: Partial Oral Antimicrobials to Treat Infective Endocarditis in People Who Inject Drugs

Recruiting
N/A
50
Canada
Partial oral antimicrobial therapy
Lawson Health Research Institute
Infective Endocarditis
12/24
06/25
ICECAP, NCT04217551: Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients

Recruiting
N/A
1800
US
Therapeutic Hypothermia
University of Michigan, Johns Hopkins University, Medical University of South Carolina, National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS)
Cardiac Arrest, Out-Of-Hospital, Hypothermia, Induced, Hypoxia-Ischemia, Brain
07/28
08/28

Download Options